The exhibition at the Victoria and Albert Museum features objects from Queen Elizabeth II, Grace Kelly, Jackie Kennedy, Elizabeth Taylor, Wallis Simpson, Barbara Hutton, Daisy Fellowes and Tyler, the ...

It could have been the case that walking through the V&A’s Cartier exhibition, which is sponsored by the 1847-founded ...

A spellbinding exhibition of Cartier jewels, many never seen before in public, is opening in London tracing the history of ...

Beyond the lifestyle tips and recipes, here is a breakdown of the jewellery and watches donned by Meghan Markle on With Love, Meghan.

New takes on legacy models, new movements, high complications, interesting gem-setting, stone dials, smaller case sizes, and ...

Beyond the lifestyle tips and recipes, here is a breakdown of the jewellery and watches donned by Meghan Markle on With Love, Meghan.

Servier and Black Diamond Therapeutics have signed a licensing agreement for a targeted therapy, BDTX-4933, to treat solid tumours. Servier will be responsible for the development and the global ...

The therapy is undergoing Phase I clinical development. Credit: Alex_Traksel/Shutterstock. Servier and Black Diamond Therapeutics have signed a licensing agreement ...

Black Diamond Therapeutics has found a partner for its deprioritized solid tumor candidate. Five months after cutting support for BDTX-4933, the biotech has licensed the RAF inhibitor to Servier ...

Allow the Sale, Sharing or use of My Personal information for Targeted Advertising If you switch this toggle to “no,” we will not sell or share your personal information with third parties for ...

Servier will be responsible for the development and commercialization of BDTX-4933, a Phase I asset targeting solid tumors with RAS and RAF mutations. Black Diamond’s stock jumped more than 40% in pre ...

NEW YORK – Servier has signed a global licensing agreement with Black Diamond Therapeutics to develop and commercialize BDTX-4933 for treating RAF- and RAS-mutant solid tumors, including non-small ...